It is a healthcare private limited company based in Mumbai, Maharashtra, India, established in 2017.
2017 | Mumbai, Maharashtra, India | ActiveSygna Clinivus Private Limited, a active private limited company, was established on 22 December 2017 in Mumbai, Maharashtra, India. Engaging in hospitals within the healthcare sector, it holds CIN: U85300MH2017PTC303252. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Geetanjali Snehshashank Yadav (Director), Sneh Shashank Yadav (Director). Past directors included Ashish Bharatkumar Dama, Manisha Ashish Dama, Anchalika Bhagwansingh Yadav. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 303, Sai Infotech Chs Ltd, R. B Mehta Road, Patel Chowk, Ghatkopar East, Mumbai, Maharashtra, 400077.
U85300MH2017PTC303252
303252
22 December 2017
₹1.00 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Sygna Clinivus Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Geetanjali Snehshashank Yadav | Director | 22 Dec 2017 | Current |
| Sneh Shashank Yadav | Director | 22 Dec 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 22 Mar 2021 | Past |
| Pramod Abcsdd | Additional Director | 22 Mar 2021 | Past |
| Pramod Abcsdd | Additional Director | 22 Mar 2021 | Past |
| Pramod Abcsdd | Additional Director | 22 Mar 2021 | Past |
| Pramod Abcsdd | Additional Director | 22 Mar 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sygna Clinivus Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 64.02% increase in profit. The company's net worth observed a substantial decline by a decrease of 18.23%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Sygna Clinivus had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sygna Clinivus, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sygna Clinivus, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sygna Clinivus's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sygna Clinivus Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
The activity Sygna Clinivus Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
Progress on Geetanjali Snehshashank Yadav was appointed as a Director was appointed as a Director on 22 Dec 2017 & has been associated with this company since 8 years 19 days . was documented.
Progress on Sneh Shashank Yadav was appointed as a Director was appointed as a Director on 22 Dec 2017 & has been associated with this company since 8 years 19 days . was documented.
Progress on Sygna Clinivus Private Limited was registered on 22 Dec 2017 with Roc Mumbai & aged 8 years 19 days as per MCA records. was documented.
The CIN of Sygna Clinivus Private Limited is U85300MH2017PTC303252.
Sygna Clinivus Private Limited is headquartered at 303, Sai Infotech Chs Ltd, R. B Mehta Road, Patel Chowk, Ghatkopar East, Mumbai, Maharashtra, 400077.
Sygna Clinivus Private Limited was incorporated on 22 December 2017.
The current directors of Sygna Clinivus Private Limited are
The primary industry of Sygna Clinivus Private Limited is Healthcare.
Sygna Clinivus Private Limited is unlisted.
The authorized capital of Sygna Clinivus Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Sygna Clinivus Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX